Qubic Stim Cardiac Stimulator in China

Status Completed

Clinical Trial Summary

106 subjects selected from 3 study sites in China are with indications for intracardiac electrophysiological examination. The trial is to prove the clinical effectiveness and safety of Qubic Stim Cardiac Stimulator in Chinese population.

Clinical Trial Description

The trial is a multicenter, prospective and single-arm study. 106 appropriate subjects were selected from 3 study sites in China in accordance with the inclusion and exclusion criteria. The subjects consent to participate in the trial and sign the informed consent. The subjects who meet the inclusion and exclusion criteria will receive the intracardiac electrophysiological examination, during which the subjects will be subject to diagnostic electrical stimulation by the Qubic Stim Cardiac Stimulator. The subjects will also receive the clinical follow-up visit after cardiac electrical stimulation until they are discharged from the hospital. The clinical effectiveness and safety of Qubic Stim Cardiac Stimulator in Chinese population were proved by observing the data collected in this study. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04390841
Study type	Interventional
Source	Biotronik (Beijing) Medical Device Ltd.
Contact
Status	Completed
Phase	N/A
Start date	December 1, 2020
Completion date	April 12, 2021

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05048602` - Drug-induced Brugada Syndrome Research Database
Completed	`NCT05053243` - Clinical Validation of the AliveCor Kardia 12L and 6L Devices	N/A
Completed	`NCT01913561` - The Use of Master Caution Garment for Continuous Monitoring for Arrhythmia Detection	N/A
Completed	`NCT01688648` - Comparison Between Lidocaine, Dexmedetomidine, and Their Combined Infusion in Subjects Undergoing Coronary Artery Bypass Graft	N/A
Completed	`NCT01396226` - A Multi-centre Study Comparing the Effects of AZD2927 and Placebo on the Electrical Activity in the Heart in Patients	Phase 2
Completed	`NCT00756886` - Does Atorvastatin Prevent Post Operative Atrial Fibrillation After Pulmonary Resection: A Randomized Clinical Study	N/A
Terminated	`NCT00721149` - NAVISTAR® THERMOCOOL® Catheter for the Radiofrequency Ablation of Symptomatic Paroxysmal Atrial Fibrillation- Treatment Use Study	Phase 3
Terminated	`NCT00624520` - Mental Stress Reduction in Defibrillator Patients	Phase 3
Completed	`NCT00510029` - Single Ascending Dose Study of the Safety, Tolerability, and Pharmacokinetics of GAP-134 Administered Intravenously	Phase 1
Completed	`NCT00578617` - Ablation vs Drug Therapy for Atrial Fibrillation - Pilot Trial	N/A
Active, not recruiting	`NCT00135174` - Cost-Effectiveness of Routine Follow-up Visits in Patients With a Pacemaker: The Followpace Study	N/A
Completed	`NCT00119847` - Electrophysiological Effects of Late PCI After MI	N/A
Completed	`NCT00035490` - Efficacy and Safety Evaluation of Azimilide Dihydrochloride in Patients With Implantable Cardioverter Defibrillators	Phase 3
Completed	`NCT00023556` - Genetic Architecture of Heart Disease in Rural Brazil	N/A
Completed	`NCT01076361` - Model 4968 CAPTURE EPI® STERIOD-ELUTING BIPOLAR EPICARDIAL PACING LEAD Post-approval Study	N/A
Completed	`NCT00004560` - Public Access Defibrillation (PAD) Community Trial	Phase 3
Recruiting	`NCT00138931` - Genetics of Cardiovascular and Neuromuscular Disease
Completed	`NCT00622453` - Arrhythmias in Myotonic Muscular Dystrophy	N/A
Completed	`NCT01076348` - Model 4965 Post-Approval Study
Completed	`NCT00000531` - Antiarrhythmics Versus Implantable Defibrillators (AVID)	Phase 3